CAS: 82009-34-5; (Z)-7-(((R)-2-Amino-2-Carboxyethyl)Thio)-2-((S)-2,2-Dimethylcyclopropane-1-Carboxamido)Hept-2-Enoic Acid

该化合物是肾上脱氢抑制剂I(DHP-1)的一种选择性的,可逆的抑制剂, 一种酶, 导致某些乙状乳性抗生素, 如imipenem 的降解. 通过抑制 DHP-1, 硅, 防止这些抗生素的肾代谢, 从而提高其尿道恢复能力并延长其治疗效果. 这个机制在混合疗法中特别宝贵, 与 imipenem 共同管理 硅, 以提高 药理基因稳定性并减少 ...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

L-Cysteine (Z)-7-bromo-2 ((2s)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid 1,5-dibromo-pentane 2,2-dimethylcyclopropane-1-carboxylic acid

合成工艺路线路线简述

  • 合成目标产物 Cilastatin 主要起始原料 7-Chloro-2-[[[(1S)-2,2-Dimethylcyclopropyl]Carbonyl]Amino]-2-Heptenoic Acid And L-Cysteine Monohydrochloride
  • 52-90-4 + 166037-21-4 = 82009-34-5
    反应条件:1.1 Reagents: Sodium,Potassium Iodide Solvents: Methanol,Toluene1.2 -
    标题:New Approach To The Synthesis Of Cilastatin,The Inhibitor Of Renal Dipeptidase
    作者:Vinogradov,M. G.; Kaigorodova,L. N.; Chel'Tsova-Bebutova,G. V.; Gorshkova,L. S.; Starostin,E. K.; Et Al
    参考文献:Izvestiya Akademii Nauk 日期:1995 卷标:(1) 页码:171-5]

    52-90-4 + 78834-80-7 = 82009-34-5
    反应条件:1.1 Reagents: Sodium Solvents: Methanol,Ammonia
    标题:Inhibition Of The Mammalian β-Lactamase Renal Dipeptidase (Dehydropeptidase-I) By Z-2-(Acylamino)-3-Substituted-Propenoic Acids
    作者:Graham,Donald W.; Ashton,Wallace T.; Barash,Louis; Brown,Jeannette E.; Brown,Ronald D.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:1987 卷标:30(6) 页码:1074-90
7-Bromo-2-Oxoheptanoic Acid置于氨,Sodium体系中,用 甲苯 作为反应溶剂,化学反应 0.25H,反应生成 西司他丁
参考文献:Inhibition Of The Mammalian .Beta.-Lactamase Renal Dipeptidase (Dehydropeptidase-I) By Z-2-(Acylamino)-3-Substituted-Propenoic Acids
标题:Inhibition Of The Mammalian .Beta.-Lactamase Renal Dipeptidase (Dehydropeptidase-I) By Z-2-(Acylamino)-3-Substituted-Propenoic Acids
摘要:The Title Enzyme Deactivates The Potent Carbapenem Antibiotic Imipenem In The Kidney,Producing Low Antibiotic Levels In The Urinary Tract. A Series Of (Z)-2-(Acylamino)-3-Substituted-Propenoic Acids (3) Are Specific,Competitive Inhibitors Of The Enzyme Capable Of Increasing The Urinary Concentration Of Imipenem In Vivo. Many Of The Compounds Were Prepared In One Step From An Alpha-Keto Acid And A Primary Amide. The Optimum R2 Groups Are 2,2-Dimethyl,-Dichloro,And-Dibromocyclopropyl. With R2 = 2,2-Dimethylcyclopropyl (Dmcp),A Wide Variety Of R3 Groups Including Alkyl,Oxa-And Thiaalkyl,And Alkyl Groups Containing Acidic,Basic,And Neutral Substituents Give Effective Inhibitors With Ki Values Of 0.02-1 Microm And A Range Of Pharmacokinetic Properties. By Resolution Of Enantiomers And X-Ray Crystallography,The Enzyme-Inhibitory Activity Of The Dmcp Group Was Found To Reside With The 1S Isomer. The Cysteinyl Compound 176 (Cilastatin,Mk-0791) Has The Desired Pharmacological Properties And Has Been Chosen For Combination With Imipenem.
DOI:10.1021/jm00389A018

海关参考信息

专利信息


专利号:US-2024197774-A1
优先权日:2021-04-16
标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
权利人:UNIV TEXAS
摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

专利号:US-2023286915-A1
优先权日:2020-10-07
标 题 :Synthesis of pyrrole acid derivatives
发明人:WILKINSON ANDREW; COOPER LAN; ORR DAVID; FINLAYSON JONATHAN; BUNT ADAM; KIRKHAM JAMES; LYTH DAVID; BLADES KEVIN
权利人:INFEX THERAPEUTICS LTD
摘要:This invention relates to the synthesis of compounds that can be used to treat bacterial infections in combination with other antibacterial agents, and more specifically in combination with a class of antibacterial agents known as carbapenems. The compounds resulting from the novel methods of the present invention are enzyme inhibitors and more particularly are metallo-β-lactamase inhibitors.

专利号:US-11744867-B2
优先权日:2017-02-14
标 题 :Modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate in behavior and disease
发明人:NEEDHAM BRITTANY D; MAZMANIAN SARKIS K; SHARON GIL; FUNABASHI MASANORI; FISCHBACH MICHAEL A; HSIAO ELAINE Y; PATTERSON PAUL H
权利人:CALIFORNIA INST OF TECHN; UNIV CALIFORNIA
摘要:Some embodiments relate to genetically engineered bacterial strains for modulation of levels of the bacterial metabolite 4-ethylphenol (4EP) and its sulfated form, 4-ethylphenyl sulfate (4EPS). In some embodiments, the bacteria reduce or inhibit production of 4EP or 4EPS in the gut of a subject. The bacteria can ameliorate, delay the onset, or reduce the likelihood of one or more symptoms associated with anxiety and/or autism spectrum disorder (ASD) in the subject.

专利号:US-8557979-B2
优先权日:2004-06-10
标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
发明人:CHOI WOO-BAEG; KOWALIK EWA
权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

专利号:US-2022233673-A1
优先权日:2019-06-04
标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

专利号:US-10933051-B2
优先权日:2017-06-09
标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections
发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN
权利人:FOB SYNTHESIS INC
摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.
上海皋申化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lxxgaoshen.com
企业联系电话:18717810934;13402137219👤
📞上海皋申化工有限公司 ⚠️参考联系方式
联系人:刘先生
电话:18717810934;13402137219
手机:18717810934;13402137219
传真:021-51200342
邮箱:lxx599@163.com
通信地址: 上海市普陀区铜川路70号1911室
邮编: 200061
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市普陀区铜川路70号1911室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海诺吉化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: https://www.norkypharm.com
电话: 021-021-61075308 15216782696👤
📞上海诺吉化工科技有限公司 ⚠️参考联系方式

销售电话:021-021-61075308 15216782696
邮箱:sales@norkysh.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江海翔药业股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hisoar.com
电话: 0576-89088179👤
📞浙江海翔药业股份有限公司 ⚠️参考联系方式

销售电话:0576-89088179
邮箱:info@hisoar.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Davani F, Alishahi M, Sabzi M, Khorram M, Arastehfar A, Zomorodian K. Dual drug delivery of vancomycin and imipenem/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections. Mater Sci Eng C Mater Biol Appl. 2021 Apr;123:111975. doi: 10.1016/j.msec.2021.111975. Epub 2021 Feb 15. 81(3):377-388. doi: 10.1007/s40265-021-01471-8. Epub 2021 Feb 25.
3: Yamada K, Jahangiri Y, Li J, Gabr A, Anoushiravani A, Kumagai K, Uchida B, Farsad K, Horikawa M. Embolic Characteristics of Imipenem-Cilastatin Particles in Vitro and in Vivo: Implications for Transarterial Embolization in Joint Arthropathies. J Vasc Interv Radiol. 2021 Feb
16:S1051-0443(21)00336-5. doi: 10.1016/j.jvir.2021.02.006. Epub ahead of print. 78(8):674-683. doi: 10.1093/ajhp/zxab012. 65(4):e02141-20. doi: 10.1128/AAC.02141-20. 22(3):1239. doi: 10.3390/ijms22031239.

合成参考文献


参考文献:10.1186/cc8877
摘要:Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, Valin N, Desmonts JM, Montravers P. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care. 2010;14(1):R20.
参考文献:10.1186/1756-0500-4-236
摘要:Marinho DS, Huf G, Ferreira BL, Castro H, Rodrigues CR, de Sousa VP, Cabral LM. The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital. BMC Res Notes. 2011 Jul 15;4():236.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知